DeviceSpace.com
Medical Device and Diagnostics
News & Jobs
 
Search the Site
    
 
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login           Employers:  Register | Login  
Medical Device Companies | Diagnostic Companies | Organizations | Search Profiles
 Company Profile

 

Eli Lilly and Company 

Lilly Corporate Center

Indianapolis  Indiana  46285  U.S.A.
Phone: 317-276-2000 Fax: n/a


SEARCH JOBS

View Clinical Trials from BioPharm Insight

Lilly makes medicines that help people live longer, healthier, more active lives. We were founded by Eli Lilly in 1876, and are now the 10th largest pharmaceutical company in the world. We have steadfastly remained independent, but not isolated. Across the globe, Lilly has developed productive alliances and partnerships that advance our capacity to develop innovative medicines at lower costs. Lilly is consistently ranked as one of the best companies in the world to work for, and generations of Lilly employees have sustained a culture that values excellence, integrity, and respect for people. Lilly's global employees number approximately 40,000, and our medicines are marketed in 143 countries. Lilly has major research and development facilities in eight countries and conducts clinical trials in more than 50 countries.

Making medicines has never been easy. But in today's global health care environment, the challenges are unprecedented. Familiar ways of working aren't working anymore, so Lilly is transforming to meet the challenges head on — from how we make medicines to how we talk about them. Throughout our organization, we're asking tough questions and discovering better answers.

Around the world people are in need of health care. People with medical needs above and beyond the capabilities of existing medicine. It is here, at the edge of science and medicine that Lilly begins. Lilly has embraced a bold vision. We intend to make a significant contribution to humanity by improving global health in the 21st century. Starting with the work of our scientists, we will place improved outcomes for individual patients at the center of what we do. We will listen carefully to understand patient needs and work with health care partners to provide meaningful benefits for the people who depend on us.

Lilly, a leading innovation driven corporation, is developing a growing portfolio of pharmaceutical products by applying the latest research from its own worldwide laboratories and from collaborations with eminent scientific organizations. Headquartered in Indianapolis, Ind., Lilly provides answers through medicines and information for some of the world’s most urgent medical needs.


 Key Statistics


Email:
Ownership: Public

Web Site: Eli Lilly and Company
Employees: 41,500 globally
Symbol: LLY
 





Collaborations

Incyte Corporation 

SLIL Biomedical Corporation  Worldwide licensing agreement with the animal health division for more than 40 compounds that have shown activity in animal infectious diseases.

Emisphere Technologies, Inc.  Osteoporosis; Growth disorders

PanVera LLC 

Medarex, Inc. 

MacroGenics, Inc. 

Daiichi Sankyo, Inc. 

Dyax Corp.  Antibody phage display





 Company News
Eli Lilly and Company (LLY) Release: New Study Shows Beta-Amyloid Imaging Is Associated With Altered Diagnosis And Management Of Alzheimer's Disease 7/16/2014 9:33:54 AM
Eli Lilly and Company (LLY) Inks $45 Million Immunotherapy Development Deal With Immunocore Limited 7/16/2014 7:45:35 AM
Eli Lilly and Company (LLY) Release: New Data Shows Cognitive Impairment Precedes And Predicts Subsequent Functional Impairment In Patients With Mild Alzheimer's Disease 7/15/2014 8:48:27 AM
Anthera Pharmaceuticals, Inc. (ANTH) Announces Acquisition Of Sollpura® (liprotamase) For Exocrine Pancreatic Insufficiency From Eli Lilly and Company (LLY) 7/15/2014 8:45:19 AM
A Peek At Eli Lilly and Company (LLY)'s Strategy For Managing Digital Health Risks 7/15/2014 7:06:33 AM
Eli Lilly and Company (LLY) Release: New Data Shows Combination Therapy Is More Effective Than Monotherapy In Removing Beta-Amyloid Plaques From The Brains Of Mice 7/14/2014 9:08:19 AM
Eli Lilly and Company (LLY) For Better Health™ Expands Website's Non-Product-Branded Health Education Resources, Focuses On Healthy Behavior Skills 7/11/2014 9:24:38 AM
Eli Lilly and Company (LLY) Confirms Date And Conference Call For Second-Quarter 2014 Financial Results Announcement 7/9/2014 9:45:11 AM
Sanofi (France) (SAN.PA) Sues Eli Lilly and Company (LLY) Over Insulin Rival To Lantus 7/9/2014 7:22:06 AM
Eli Lilly and Company (LLY) To Showcase Data From Its Alzheimer's Disease Portfolio At The Alzheimer's Association International Conference 2014 (AAIC 2014) 7/8/2014 9:39:37 AM
12345678910...